GLPG 股價走勢圖
GLPG 股票價格預測
Lakefront Biotherapeutics NV
$28.9
-0.13%
$-0.04
收盤價：Jun 12, 16:00:00 GMT-4
$28.93
0.1%
$0.03
盤後：Jun 12, 20:00:00 GMT-4
返回
Lakefront Biotherapeutics NV (GLPG) 股票價格預測
According to analyst forecasts, we anticipate notable price fluctuations for GLPG in the upcoming periods. Looking toward the future, our 2027 projection indicates an average price target of $34.28. The lowest target is $21.8 and the highest is $53.45. Empower your investment choices with our cutting-edge, data-driven analysis!
GLPG 股價預測摘要
我應該買 GLPG 嗎？
GLPG 的頂級分析師評級
根據 17 位分析師對 GLPG 的股票評級，更新於 Oct 01, 2025
Strong buy
1
Buy
1
Hold
5
Sell
7
Strong sell
3
Based on comprehensive analyst evaluations, we have synthesized critical insights from expert assessments to outline a cautious outlook for GLPG. Analysts note deteriorating fundamentals and challenging market sentiment, indicating potential downside risks in the near term. Following this expert analysis, we adopt a bearish stance on this stock. Our conclusion: GLPG is a Sell candidate.
GLPG stock price ended at $28.94 on 星期四, after rising 1.15%
On the latest trading day Jun 11, 2026, the stock price of GLPG rose by 1.15%, climbing from $28.50 to $28.94. Throughout the session, the stock experienced a volatility of 2.08%, with prices fluctuating between a daily low of $28.43 and a high of $29.02. Alongside this price increase, trading volume also rose by 130.2K shares, reflecting strong market interest that may signal continued bullish momentum in the near term. In total, 161.2K shares were traded, amounting to a market value of approximately $1.9B.
GLPG 技術面訊號
技術面訊號摘要
Strong Sell
Sell
Neutral
Buy
Strong Buy
GLPG 目前顯示 3 個買入訊號與 3 個賣出訊號。該股票自 12:00 AM 以來一直處於 上升趨勢 狀態，在此期間價格總共變動了 3.99%。整體而言，技術指標顯示中期後市趨勢為 Neutral。
GLPG 的看漲／看跌訊號
我們的演算法透過分析移動平均線、RSI、MACD 和成交量等關鍵指標，為GLPG生成看漲和看跌訊號。這些見解可助您做出明智的投資決策。
後續問題
技術分析指標如何適用於 GLPG？
GLPG 的費波那契回檔水準是多少？
Lakefront Biotherapeutics NV 的 RSI 是多少？
Lakefront Biotherapeutics NV 接下來 12 個月的價格是多少？
Lakefront Biotherapeutics NV 預計會漲到多高？
關鍵數據
前收市價
$28.94
開盤價
$28.8
當日範圍
$28.64 - $29.05
52週區間
$26.62 - $37.78
交易量
--
平均成交量
154.8K
股息收益率
--
每股盈餘 (TTM)
8.71
市值
$1.9B
什麼是 Galapagos NV？
Galapagos NV 是一家生物技術公司，致力於小分子和抗體療法的識別與開發。該公司總部位於比利時梅赫倫 (Mechelen)，安特衛普，目前擁有 704 名全職員工。公司於 2005 年 5 月 6 日上市。該公司致力於發現與開發具有特定作用機制的小分子藥物。其研發產品線包括第三期、第二期、第一期、臨床前研究，以及針對囊性纖維化、炎症及其他適應症的小分子與抗體項目。公司專注於開發臨床階段療法組合，以提升現有的治療方式。透過結合內部與外部科學，公司致力於研發具有突破性的藥物，以滿足高未滿足醫療需求的領域，為全球患者延長生命並改善生活品質。公司發現了與疾病相關的蛋白質，例如類風濕性關節炎、炎症性腸道疾病和纖維化。為了開發細胞療法（一種潛在的癌症變革性治療方法），公司收購了 CellPoint 和 AboundBio。
